SHNXY (Shandong Xinhua Pharmaceutical Co) Moat Score: 0/10 (As of Jul. 08, 2026)


SHNXY Shandong Xinhua Pharmaceutical Co Ltd SHNXY
75 GF Score
Price $18.19
GF Value $21.89
! 5 Warning Signs
View Full Analysis

What is Shandong Xinhua Pharmaceutical Co Moat Score?

Shandong Xinhua Pharmaceutical Co has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Shandong Xinhua Pharmaceutical Co has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Shandong Xinhua Pharmaceutical Co might have No Moat - No discernible moat.

Shandong Xinhua Pharmaceutical Co  (OTCPK:SHNXY) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Shandong Xinhua Pharmaceutical Co Moat Score Related Terms

SHNXY
75GF Score
Shandong Xinhua Pharmaceutical Co Ltd SHNXY
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shandong Xinhua Pharmaceutical Co (SHNXY) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Xinhua Pharmaceutical Co stock appears to be undervalued. The current stock price of $18.19 is trading 16.9% below its estimated GF Value™ of $21.89.

Key valuation signals for SHNXY:

  • Moat Score: 0
  • GF Value™: $21.89 vs. price of $18.19 (16.9% below fair value)
  • GF Score™: 75/100 with 5 warning signs

No single metric tells the full story. See the SHNXY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shandong Xinhua Pharmaceutical Co Business Description

Address No. 1 Lutai Avenue, Hi-tech Industry Development Zone, Zibo, Shandong, CHN, 255086
Shandong Xinhua Pharmaceutical Co Ltd is a pharmaceutical products manufacturer based in China. It operates various segments namely Chemical raw materials, Preparations, Pharmaceutical intermediates and other products. The company is mainly engaged in the business of development, manufacture and sale of bulk pharmaceuticals, preparations and chemical products.
75GF Score

Get the complete analysis for SHNXY

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$18.19
Price
$21.89
GF Value